UBC Medical Indonesia Tbk. vs Bank China Construction Bank Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Bank China Construction Bank Indonesia Tbk. trades at Rp68 (market cap 2.55T, 485.4K 24h volume). The key difference: Bank China Construction Bank Indonesia Tbk. is far larger — about 4.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 485.4K). Which is the better fit depends on your goals.
| LABS | MCOR | |
|---|---|---|
Market Cap | 576.7B | 2.55T |
Volume | 3.48M | 485.4K |
Lot | 34.82K | 4.85K |
Turnover | 522.79M | 32.56M |
Average Price | 150.13 | 67.07 |
Value | 522.79M | 32.56M |
Indicative Equilibrium Price | 148 | 68 |
Indicative Equilibrium Volume | 350 | 2 |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Bank Multicor (Bank) was established under its original name of PT Multinational Finance Corporation base on notarial deed No.4 of Mr Bagijo, S.H, dated on Apr 2, 1974. The Company’s articles of association has been amended several times, most recently by notarial deed No. 143 of Eliwati Tjitra, S.H., dated Mar 21, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering. The Bank's name was changed to PT Bank Windu Kentjana International Tbk.
Read more on MCOR →